tradingkey.logo
tradingkey.logo
Search

Ascendis Pharma A/S

ASND
Add to Watchlist
232.910USD
-32.010-12.08%
Market hours 09/15, 12:13ET
15.42BMarket Cap
33.56P/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-12.08%

5 Days

-13.92%

1 Month

-6.27%

6 Months

+3.07%

Year to Date

+9.22%

1 Year

+19.09%

Key Figures

260.135Open
256.630High
130.64KVolume
33.56P/E TTM
20.29P/E Dynamic
--Dividend TTM
0.20%Turnover Ratio
264.920Prev. Close
228.700Low
30.69MTurnover
LossP/E Static
9.31P/B
0.00%Div Yield TTM
32.36%ROA
282.15052wk High
0.62Volume Ratio
-378.08MNet Profit
66.19MShares
6.9400EPS TTM
0.41Beta
332.65%ROE
186.05452wk Low
10.54%Amplitude
91.85%Gross Margin
15.42BMarket Cap
-0.55Reward/Risk
2.34%Risk Rate

Ascendis Pharma A/S's Score

0.01vs previous score
Forecast9.00
Financial Health9.22
Technical3.33
Valuation Dimensions9.26
Institutional Confidence10.00
Risk Assessment7.60

Media Coverage

Coverage Level

Very Low
Very High
Positive+

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
316.564Target Price
+20.13%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy1010999999
Buy1010999988
Hold00000000
Sell00000000
Strong Sell00000000

Ascendis Pharma A/S Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Strong sell

Summary

Sell

Moving Average

Strong sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
3.68/1.60
Revenue / Forecast
391.09M/383.58M

Ascendis Pharma A/S Profile

SectorBiotechnology & Medical Research
Ticker SymbolASND
Number of employees0
CountryDenmark

Ownership

ShareholdersProportion
RA Capital Management, LP16.55%
Avoro Capital Advisors LLC8.23%
Westfield Capital Management Company, L.P.7.75%
Janus Henderson Investors6.54%
Shareholder TypesProportion
Investment Advisor/Hedge Fund42.09%
Investment Advisor35.69%
Venture Capital16.77%
Hedge Fund6.19%

FAQs

What is the current price of Ascendis Pharma A/S (ASND)?

The current price of Ascendis Pharma A/S (ASND) is 264.92.

What is the symbol of Ascendis Pharma A/S?

The ticker symbol of Ascendis Pharma A/S is ASND.

What is the 52-week high of Ascendis Pharma A/S?

The 52-week high of Ascendis Pharma A/S is 282.15.

What is the 52-week low of Ascendis Pharma A/S?

The 52-week low of Ascendis Pharma A/S is 186.05.

What is the market capitalization of Ascendis Pharma A/S?

The market capitalization of Ascendis Pharma A/S is 17.52B.

Is Ascendis Pharma A/S (ASND) currently rated as Buy, Hold, or Sell?

According to analysts, Ascendis Pharma A/S (ASND) has an overall rating of Buy, with a price target of 316.56.

What is the Earnings Per Share (EPS TTM) of Ascendis Pharma A/S (ASND)?

The Earnings Per Share (EPS TTM) of Ascendis Pharma A/S (ASND) is 6.94.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.